XML 21 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred stock
Common stock
Surplus
Treasury stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Balance at beginning of period at Dec. 31, 2020 $ 4,115,995   $ 412,500 $ 58,473 $ 1,649,990 $ (100,363) $ 2,080,013   $ 15,382
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 466,151           466,151    
Other comprehensive income (loss), net of tax (11,290)               (11,290)
Cash dividends declared on common stock (70,663)           (70,663)    
Dividends on preferred stock (27,966)           (27,966)    
Common stock repurchased under authorized program (9,540)         (9,540)      
Stock-based compensation 16,177       16,177        
Common stock issued for:                  
Exercise of stock options and warrants 14,035     327 13,708        
Restricted stock awards 0     20 (20)        
Employee stock purchase plan 3,325     48 3,277        
Director compensation plan 2,464     24 2,440        
Balance at end of period at Dec. 31, 2021 4,498,688   412,500 58,892 1,685,572 (109,903) 2,447,535   4,092
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 509,682           509,682    
Other comprehensive income (loss), net of tax (431,728)               (431,728)
Cash dividends declared on common stock (80,246)           (80,246)    
Dividends on preferred stock (27,964)           (27,964)    
Stock-based compensation 31,748       31,748        
Common stock issued for:                  
New issuance, net of costs 285,729     1,612 174,214 109,903      
Exercise of stock options and warrants 4,886     123 5,067 (304)      
Restricted stock awards 0     69 (69)        
Employee stock purchase plan 3,386     42 3,344        
Director compensation plan 2,657     59 2,598        
Balance at end of period at Dec. 31, 2022 $ 4,796,838   412,500 60,797 1,902,474 (304) 2,849,007   (427,636)
Common stock issued for:                  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2022-02                
Net income $ 622,626           622,626    
Other comprehensive income (loss), net of tax 66,405               66,405
Cash dividends declared on common stock (97,726)           (97,726)    
Dividends on preferred stock (27,964)           (27,964)    
Stock-based compensation 33,495       33,495        
Exercise of stock options and warrants 2,242     56 2,186        
Restricted stock awards (1,913)     307 (307) (1,913)      
Employee stock purchase plan 3,329     46 3,283        
Director compensation plan 2,738     63 2,675        
Balance at end of period at Dec. 31, 2023 $ 5,399,526 $ (544) $ 412,500 $ 61,269 $ 1,943,806 $ (2,217) $ 3,345,399 $ (544) $ (361,231)